What are the prescription templates for managing hypertensive emergencies in various clinical scenarios?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescription Templates for Hypertensive Emergencies

General Principles

All hypertensive emergencies (BP >180/120 mmHg with acute end-organ damage) require immediate ICU admission with continuous IV antihypertensive therapy, not oral agents. 1

Blood Pressure Reduction Targets

For patients WITHOUT compelling conditions (aortic dissection, severe preeclampsia/eclampsia, pheochromocytoma):

  • Reduce SBP by maximum 25% within first hour 1
  • Then target 160/100 mmHg over next 2-6 hours if stable 1
  • Gradually normalize BP over following 24-48 hours 1

For patients WITH compelling conditions:

  • Aortic dissection: Reduce SBP to <120 mmHg within 20 minutes 1
  • Severe preeclampsia/eclampsia or pheochromocytoma: Reduce SBP to <140 mmHg within first hour 1

Scenario 1: Acute Aortic Dissection

Prescription Template:

Esmolol IV:
- Loading dose: 500-1000 mcg/kg over 1 minute
- Maintenance infusion: 50 mcg/kg/min
- Titrate by 50 mcg/kg/min increments every 5 minutes
- Maximum: 200 mcg/kg/min
- Target: SBP ≤120 mmHg within 20 minutes

If additional BP control needed, ADD:
Nicardipine IV:
- Start: 5 mg/hr
- Increase by 2.5 mg/hr every 5 minutes
- Maximum: 15 mg/hr

OR Sodium Nitroprusside IV:
- Start: 0.3-0.5 mcg/kg/min
- Titrate by 0.5 mcg/kg/min increments
- Maximum: 10 mcg/kg/min

Critical: Beta blockade MUST precede vasodilator administration to prevent reflex tachycardia and increased aortic shear stress. 1

Alternative if beta blockers contraindicated:

Labetalol IV (combined alpha/beta blocker):
- Initial bolus: 0.3-1.0 mg/kg (maximum 20 mg) over 2 minutes
- Repeat every 10 minutes as needed
- OR continuous infusion: 0.4-1.0 mg/kg/hr up to 3 mg/kg/hr
- Maximum cumulative: 300 mg

1


Scenario 2: Acute Pulmonary Edema

Prescription Template:

Nitroglycerin IV (FIRST-LINE):
- Start: 5 mcg/min
- Increase by 5 mcg/min every 3-5 minutes
- Maximum: 20 mcg/min
- Target: Symptom relief and BP reduction

OR Clevidipine IV:
- Start: 1-2 mg/hr
- Double dose every 90 seconds until BP approaches target
- Then increase by 

CONTRAINDICATION: Beta blockers are absolutely contraindicated in acute pulmonary edema. 1

Caution: Do not use nitroglycerin in volume-depleted patients or with concurrent PDE-5 inhibitor use (risk of profound hypotension). 1


Scenario 3: Acute Coronary Syndrome (ACS)

Prescription Template:

Nitroglycerin IV (AGENT OF CHOICE):
- Start: 5 mcg/min
- Increase by 5 mcg/min every 3-5 minutes
- Maximum: 20 mcg/min

PLUS Esmolol IV (AGENT OF CHOICE):
- Loading dose: 500-1000 mcg/kg over 1 minute
- Maintenance: 50 mcg/kg/min
- Titrate by 50 mcg/kg/min every 5 minutes
- Maximum: 200 mcg/kg/min

Alternative options:
Labetalol IV:
- Bolus: 0.3-1.0 mg/kg (max 20 mg) every 10 minutes
- OR infusion: 0.4-1.0 mg/kg/hr up to 3 mg/kg/hr

OR Nicardipine IV:
- Start: 5 mg/hr
- Increase by 2.5 mg/hr every 5 minutes
- Maximum: 15 mg/hr

1

Beta blocker contraindications in ACS: Moderate-to-severe LV failure with pulmonary edema, bradycardia (<60 bpm), hypotension (SBP <100 mmHg), poor peripheral perfusion, second- or third-degree heart block, reactive airways disease. 1


Scenario 4: Acute Renal Failure

Prescription Template:

Fenoldopam IV (PREFERRED - improves renal blood flow):
- Start: 0.1-0.3 mcg/kg/min
- Increase by 0.05-0.1 mcg/kg/min every 15 minutes
- Maximum: 1.6 mcg/kg/min

OR Clevidipine IV:
- Start: 1-2 mg/hr
- Double every 90 seconds until BP approaches target
- Then increase by 

1

Fenoldopam offers specific advantage of causing natriuresis and improving renal perfusion. 2


Scenario 5: Eclampsia or Severe Preeclampsia

Prescription Template:

Hydralazine IV (DRUG OF CHOICE):
- Initial: 10 mg slow IV infusion (maximum initial dose 20 mg)
- Repeat every 4-6 hours as needed
- Onset: 10-30 minutes
- Duration: 2-4 hours

OR Labetalol IV:
- Bolus: 0.3-1.0 mg/kg (max 20 mg) every 10 minutes
- OR infusion: 0.4-1.0 mg/kg/hr up to 3 mg/kg/hr
- Maximum cumulative: 300 mg

OR Nicardipine IV:
- Start: 5 mg/hr
- Increase by 2.5 mg/hr every 5 minutes
- Maximum: 15 mg/hr

ABSOLUTE CONTRAINDICATIONS: ACE inhibitors, ARBs, renin inhibitors, and sodium nitroprusside are contraindicated in pregnancy. 1

Target: Rapid BP lowering required, SBP <140 mmHg within first hour. 1


Scenario 6: Pheochromocytoma Crisis / Catecholamine Excess

Prescription Template:

Phentolamine IV (DRUG OF CHOICE):
- Bolus: 5 mg IV
- Repeat every 10 minutes as needed to lower BP to target

PLUS (for tachycardia control AFTER alpha blockade):
Esmolol IV:
- Loading: 500-1000 mcg/kg over 1 minute
- Maintenance: 50 mcg/kg/min
- Titrate by 50 mcg/kg/min every 5 minutes
- Maximum: 200 mcg/kg/min

Alternative vasodilators (after alpha blockade):
Clevidipine IV:
- Start: 1-2 mg/hr
- Titrate as above

OR Nicardipine IV:
- Start: 5 mg/hr
- Titrate as above

Critical: NEVER give beta blockers before alpha blockade in pheochromocytoma - this causes unopposed alpha stimulation and worsening hypertensive crisis. 1

Also used for: Cocaine toxicity, amphetamine overdose, MAO inhibitor interactions, clonidine withdrawal. 1

Phentolamine contraindications: Increased intraocular pressure (glaucoma), increased intracranial pressure, sulfite allergy. 1


Scenario 7: Perioperative Hypertension

Prescription Template:

Clevidipine IV (PREFERRED - rapid titration):
- Start: 1-2 mg/hr
- Double every 90 seconds until BP approaches target
- Then increase by 

Definition: BP ≥160/90 mmHg OR SBP elevation ≥20% of preoperative value persisting >15 minutes. 1

Most common timing: During anesthesia induction and airway manipulation. 1


Scenario 8: Hypertensive Encephalopathy (No Stroke)

Prescription Template:

Nicardipine IV (FIRST-LINE):
- Start: 5 mg/hr
- Increase by 2.5 mg/hr every 5 minutes
- Maximum: 15 mg/hr
- No dose adjustment needed for elderly

OR Labetalol IV:
- Bolus: 0.3-1.0 mg/kg (max 20 mg) every 10 minutes
- OR infusion: 0.4-1.0 mg/kg/hr up to 3 mg/kg/hr
- Maximum cumulative: 300 mg

OR Clevidipine IV:
- Start: 1-2 mg/hr
- Double every 90 seconds until BP approaches target
- Then increase by 

Avoid sodium nitroprusside if possible due to risk of increased intracranial pressure and cyanide toxicity. 1, 3

Target: Reduce SBP by maximum 25% in first hour, then to 160/100 mmHg over 2-6 hours. 1


Scenario 9: Acute Myocardial Infarction with Hypertension

Prescription Template:

Nitroglycerin IV (FIRST-LINE):
- Start: 5 mcg/min
- Increase by 5 mcg/min every 3-5 minutes
- Maximum: 20 mcg/min

PLUS Beta blocker (if no contraindications):
Esmolol IV:
- Loading: 500-1000 mcg/kg over 1 minute
- Maintenance: 50 mcg/kg/min
- Titrate by 50 mcg/kg/min every 5 minutes
- Maximum: 200 mcg/kg/min

OR Labetalol IV:
- Bolus: 0.3-1.0 mg/kg (max 20 mg) every 10 minutes
- OR infusion: 0.4-1.0 mg/kg/hr up to 3 mg/kg/hr

1


Scenario 10: Unstable Angina with Severe Hypertension

Prescription Template:

Nitroglycerin IV (AGENT OF CHOICE):
- Start: 5 mcg/min
- Increase by 5 mcg/min every 3-5 minutes
- Maximum: 20 mcg/min

PLUS (if no contraindications):
Esmolol IV:
- Loading: 500-1000 mcg/kg over 1 minute
- Maintenance: 50 mcg/kg/min
- Titrate by 50 mcg/kg/min every 5 minutes
- Maximum: 200 mcg/kg/min

Alternative:
Nicardipine IV:
- Start: 5 mg/hr
- Increase by 2.5 mg/hr every 5 minutes
- Maximum: 15 mg/hr

1


Critical Administration Details

Nicardipine IV Administration 4:

Dilution (single dose vials):
- Each 25 mg vial diluted with 240 mL compatible IV fluid
- Final concentration: 0.1 mg/mL

Compatible fluids:
- Dextrose 5%
- Dextrose 5% + NaCl 0.45% or 0.9%
- Dextrose 5% + 40 mEq Potassium
- NaCl 0.45% or 0.9%

INCOMPATIBLE: Sodium Bicarbonate 5%, Lactated Ringer's

Administration:
- Via central line OR large peripheral vein
- Change infusion site every 12 hours if peripheral
- Protect from light until use
- Stable for 24 hours at room temperature

Sodium Nitroprusside Critical Safety 1:

Cyanide toxicity prevention:
- For infusion rates ≥4-10 mcg/kg/min OR duration >30 minutes:
  Co-administer sodium thiosulfate

Monitoring:
- Intra-arterial BP monitoring recommended
- Use shortest duration possible
- Lower doses required for elderly

Toxicity signs:
- Irreversible neurological changes
- Cardiac arrest
- Tachyphylaxis with extended use

Clevidipine Contraindications 1:

  • Soybean, soy product, egg, or egg product allergy
  • Defective lipid metabolism (pathological hyperlipidemia, lipoid nephrosis, acute pancreatitis)
  • Use low-end dose range for elderly patients
  • Maximum duration: 72 hours

Drugs to AVOID in Hypertensive Emergencies

NEVER USE: 5, 3, 6

  • Immediate-release nifedipine (causes uncontrolled BP drops, stroke, death)
  • Oral agents for true emergencies (inadequate control, unpredictable response)
  • Hydralazine as first-line (unpredictable response, prolonged duration except in eclampsia)

USE WITH EXTREME CAUTION:

  • Sodium nitroprusside (cyanide toxicity, increased ICP, requires arterial line monitoring) 1, 5, 3

Monitoring Requirements

All hypertensive emergencies require: 1

  • ICU admission
  • Continuous BP monitoring (arterial line preferred for nitroprusside)
  • Continuous cardiac monitoring
  • Frequent assessment of target organ function
  • Adjustment of infusion rate every 5-15 minutes until target reached

Transition to oral therapy: 4

  • Initiate oral antihypertensive upon discontinuation of IV therapy
  • If switching to nicardipine capsules TID: Give first oral dose 1 hour before stopping infusion
  • For other oral agents: Start immediately upon IV discontinuation

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertensive emergencies. Etiology and management.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003

Research

Hypertensive crisis.

Cardiology in review, 2010

Research

Management of hypertensive urgencies and emergencies.

Journal of clinical pharmacology, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.